Search for: "In Interest of Ep" Results 281 - 300 of 1,007
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Jul 2021, 4:00 am by Administrator
It is the monthly e-newsletter of the Canadian Association of Law Libraries (CALL) and contains news from CALL committees and special interest groups, member updates and events. [read post]
15 Jul 2021, 3:03 am by Greg Lambert and Marlene Gebauer
Dentons Nextlaw Labs‘ Maya Markovich understands that rational lawyers would observe market dynamics and client pressures to weigh the costs and benefits of adapting their behaviors to survive change, stay employed, and make their work more fulfilling. [read post]
13 Jul 2021, 6:11 am by Annsley Merelle Ward
Teva Pharmaceutical Industries Ltd and Teva Pharma Belgium NVTeva is the exclusive licensee of EP 2 949 335 (“EP’335”), a European patent relating to a low frequency glatiramer acetate therapy owned by Yeda Research and Development Co. [read post]
12 Jul 2021, 9:52 am by Populus Radio, Robert Ambrogi
  Listeners may also be interested in the April 19, 2021, episode of LawNext, in which Ironclad’s CEO Jason Boehmig was interviewed. [read post]
12 Jul 2021, 4:29 am by Tom Kosakowski
The interest here is in service demonstrating a deep understanding of OO SoP/EP and years of actual service. [read post]
2 Jul 2021, 11:39 pm by Kluwer Patent blogger
The average time to grant for EP first filings has fallen by 3.3 months over the past year to 43.9 months from filing to grant (end of Q1 2021). [read post]
27 Jun 2021, 3:01 am by Rose Hughes
Whilst the court proceedings are ongoing, some interesting background to the case can be found in arguments made by Carpmaels in the request for re-establishment of the appeal deadline. [read post]
10 Jun 2021, 3:32 am by Greg Lambert and Marlene Gebauer
As we make our way to the next version of the workforce in a post-pandemic world, we look back at a discussion of the Delta Model Competencies with Northwestern Law School’s Alyson Carrel and Vanderbilt Law School’s Cat Moon. [read post]
3 Jun 2021, 3:09 am by Greg Lambert and Marlene Gebauer
Back in Ep. 112, we talked with Dan Packel about FisherBroyles’ desire to show that a distributed law firm could compete with the AmLaw200 firms. [read post]
27 May 2021, 12:45 pm by Miquel Montañá (Clifford Chance)
The facts of the case relevant to this blog may be summarized as follows: A Spanish company filed a revocation action against patent EP 888 289 (“EP ‘289”) and its corresponding SPC, which protects lacosamide, an antiepileptic drug. [read post]
27 May 2021, 3:04 am by Greg Lambert and Marlene Gebauer
And it was an interesting article, he wrote about the rising cost of mental fatigue and how technology is the solution, as well as the problem at law firms. [read post]
17 May 2021, 5:33 am by Rose Hughes
Both the Ezetrol and Inegy SPCs were based on the same Irish patent (EP (IE) 0 720 599). [read post]
17 May 2021, 12:45 am by Annsley Merelle Ward
According to the District Court, “the falling back on the auxiliary requests can, in terms of legal consequences, be equated with the abandonment of EP 679 NL as granted. [read post]
13 May 2021, 3:17 am by Greg Lambert and Marlene Gebauer
The interesting part Marlene, is that the team members are expected to develop a creative solution to a real life client or business challenge. [read post]